Add to Basket
Order hotline:
+1 404 474 4654
+1 888 205 9894 (TF)

Interleukin 6 (IL6) antibody

Antigen

Interleukin 6 (IL6)

Synonyms HGF, HSF, BSF2, IL-6, IFNB2, Il-6, ILg6, Ifnb2, IL6, il-6
Clonality Polyclonal
Host
Alternatives

Rabbit

Reactivity
Alternatives

Human

Application
Alternatives Flow Cytometry (FACS), Immunocytochemistry (ICC), Neutralization (Neut), ELISA, Western Blotting (WB), Immunoprecipitation (IP)
2 references available
Catalog no. ABIN103144
Quantity 1ml  (75 mg/ml (by Refractometry))  (Variants)
Price 309.00 $   Plus shipping costs $35.00
Shipping to
Availability Ships within 5 Business Days

Additional Information

Alternative name Interleukin 6 (IL-6)
Immunogen This whole rabbit serum was prepared by repeated immunizations with recombinant human IL-6 produced in E.coli.
Format Liquid (sterile filtered)
Specificity This antiserum detects recombinant and native IL-6 present in body fluids and cell supernatants in various assays (i.e. IL-1 stimulated IL-6 production from fibroblasts). In Western blot analysis of natural cell products or human body fluids, multiple bands of IL-6 will appear due to the variable amount of glycosylation on the molecule. The antiserum is also useful for neutralization of human IL-6 activity in bioassays. For neutralization, incubate the sample with a 1:400 dilution of the antiserum for at least 4 hours before testing. A control of similarly diluted normal rabbit IgG (heat inactivated) is recommended. In neutralization experiments in vitro, this antibody does not result in enhanced activity of IL-6. However, because antibodies to IL-6 may act as a soluble receptor in vivo, some antibodies to IL-6 act as carriers and enhance IL-6 activity. Protein Sequence: Human Interleukin 6, 212 aa, predicted MW 23.7 kDa 1 mnsfstsafg pvafslglll vlpaafpapv ppgedskdva aphrqpltss eridkqiryi 61 ldgisalrke tcnksnmces skealaennl nlpkmaekdg cfqsgfneet clvkiitgll 121 efevyleylq nrfesseeqa ravqmstkvl iqflqkkakn ldaittpdpt tnaslltklq 181 aqnqwlqdmt thlilrsfke flqsslralr qm

Application Details

Application Notes Recommended Dilutions: ELISA 1:1,000 - 1:5,000 Use as detection antibody WESTERN BLOT 1:500 - 1:2,000 Use 2 x 10 6 endotoxin-stimulated human PBMC IMMUNOHISTOCHEMISTRY 1:400 - 1:800 Use paraffin fixation or cryofixation IMMUNOPRECIPITATION 1:400 - 1:800 Pre-clearing with non-specific rabbit IgG RADIOIMMUNOASSAY 1:4,000 - 1:8,000 User Optimized NEUTRALIZATION 1:400. Pre-clearing with non-specific rabbit IgG. OTHER APPLICATIONS User Optimized. Note: This antiserum has been tested for use in neutralizations, ELISA, immunohistochemistry, radioimmunoassay, immunoprecipitation and immunoblotting. It recognizes IL-6. Reactivity in other immunoassays is unknown. For immunoblotting, use the supernatants or lysates of 2 x 10 6 endotoxin-stimulated human peripheral blood mononuclear cells (PBMC). PBMC are stimulated for 24 hours with 1% (v/v) human serum plus 10 ng/mL E.coli LPS. For immunohistochemistry, either paraffin fix or cryofix tissue. For immunoprecipitation, pre-clearing with a non-specific rabbit IgG is helpful to reduce background. For use in ELISA formats, this antibody is best used as the second antibody in combination with a monoclonal antibody as the capture antibody.
Concentration 75 mg/ml (by Refractometry)
Buffer Stabilizer: None. Preservative: 0.01% (w/v) Sodium Azide. Buffer: 0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2.
Storage Store vial at -20° C prior to opening. Dilute only prior to immediate use. For extended storage, aliquot contents and freeze at -20° C or below. Avoid cycles of freezing and thawing. Expiration date is six (6) months from date of opening.
Research Area Cytokines, Receptors, Inflammation, Immunology, Cancer, Virology
Restrictions For Research Use only

Publications

Publications Kanbe, Inoue, Inoue et al.: "Inducement of mitogen-activated protein kinases in frozen shoulders." in: Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association, Vol. 14, Issue 1, pp. 56-61, 2009 (PubMed).

Kanbe, Chen, Nakamura et al.: "Inhibition of MAP kinase in synovium by treatment with tocilizumab in rheumatoid arthritis." in: Clinical rheumatology, 2011 (PubMed).